TwoStep Therapeutics is a biotechnology company developing a pipeline built around a versatile targeting peptide “PIP” that binds selectively to multiple tumor-associated integrins, a unique feature that enables it to deliver various payloads to virtually any solid tumor. The company leverages this technology to create targeted cancer therapies for drug delivery and radioligand therapy. TwoStep Therapeutics was co-founded by CEO, Caitlyn Miller, in collaboration with world-renowned academic entrepreneurs at Stanford University, including Nobel Laureate Carolyn Bertozzi, Jennifer Cochran, and Ronald Levy. For more information, visit www.twosteptx.com.
Company Details
- Employees
- 5
- Address
- San Carlos, California, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.twosteptx.com
- HQ
- San Carlos, California
Twostep Therapeutics Questions
Twostep Therapeutics's website is http://www.twosteptx.com
Twostep Therapeutics's LinkedIn profile is https://www.linkedin.com/company/twostep-therapeutics
Twostep Therapeutics has
5 employees.
View email and phone details for 5
employees at Twostep Therapeutics.
Twostep Therapeutics's industry is
Biotechnology Research
Twostep Therapeutics's top competitors are
Mbc Biolabs,
Radar Therapeutics,
Zipbio,
Gentibio,
Renewalbio,
Illuminant Surgical,
La Jolla Labs Inc.,
Velocity Bio,
Genesis Therapeutics,
Centivax.
Twostep Therapeutics's categories are Biotechnology Research
